Sponsored by Boehringer Ingelheim
An innovative, noninsulin drug option has arrived for the management of feline diabetes: the sodium-glucose cotransporter-2 inhibitor. In this episode of Clinician’s Brief Partner Podcast, host Dr. Beth invites Dr. Christopher Byers to discuss this novel option and how it is changing clinical strategies in the approach to feline diabetes. From case selection and monitoring to pet owner education and more, this episode will answer all your FAQs and leave you feeling ready to implement the latest pharmaceutical in practice.
Resource:
Contact us:
Podcast@briefmedia.com
Where to find us:
Twitter:
Instagram:
The Team:
Beth Molleson, DVM - Host
Sarah Pate - Producer & Project Manager, Brief Studio
Randall Stupka - Podcast Production & Sound Editing
